-
ECL Chemiluminescent Substrate Detection Kit Guide
2026-08-26
Build a sensitive, reproducible western blot workflow for scarce targets such as PRDX5 in retinal ischemia-reperfusion models. This guide combines horseradish peroxidase (HRP) chemiluminescence with practical exposure, antibody-dilution, membrane, and troubleshooting strategies for low-background protein analysis.
-
Dhx9 Helicase Directs TH17 Autoimmunity
2026-08-26
Su et al. identify the nuclear helicase Dhx9 as a chromatin-level regulator of TH17 lineage commitment, linking IL-6–STAT3 signaling to accessibility at the Rorc and Il17 loci. Genetic deletion and pharmacological inhibition reduced TH17 differentiation and autoimmune disease severity in mouse models, highlighting transcriptional-program control as a potential complement to cytokine blockade.
-
Intraperitoneal CAR-M Programming for Cancer Immunotherapy
2026-08-25
Gu et al. developed a macrophage-targeted mRNA-LNP platform for in situ evaluation of 36 CAR formats in peritoneal cancer. Their results identify a CD3ζ–TLR4 intracellular-domain design that sustains inflammatory macrophage activity, reshapes the tumor microenvironment, expands TCF1+PD-1+ progenitor-exhausted CD8+ T cells, and enhances PD-1/PD-L1 therapy.
-
Resazurin Cell Viability Assay Kit Guide
2026-08-25
The Resazurin Cell Viability Assay Kit provides fluorescence- or colorimetric-based measurement of cellular metabolic activity as a practical cell viability assay. Its ready-to-use format, broad sample compatibility, and reported fluorescence sensitivity support streamlined proliferation studies and high-throughput screening.
-
Deuterium-Labeled Degarelix: Synthesis and Significance
2026-08-24
The reference study presents a practical route to deuterium-labeled degarelix acetate for use as an internal standard in pharmacokinetic and ADME investigations. Its main contribution is the incorporation of a deuterated naphthyl amino-acid building block using D2O/D3PO4 followed by peptide synthesis, producing the labeled antagonist in 13 steps and 14% overall yield.
-
Radicicol: A Translational Map for Hsp90 Inhibition
2026-08-24
Radicicol offers translational researchers a useful bridge between Hsp90 biology, ATP-dependent kinase regulation, adipocyte differentiation, apoptosis, and inflammatory signaling. This thought-leadership guide frames how to use APExBIO A4067 as a mechanistically disciplined tool across 3T3-L1, ovarian carcinoma, and sepsis inflammation model workflows while distinguishing established evidence from forward-looking hypotheses.
-
Multi-Omics Maps ARID1A-Linked Melanoma Resistance
2026-08-23
The reference study integrates transcriptional, proteomic, and signaling data to define how ARID1A loss rewires melanoma responses to BRAF/MAPK inhibition. Its identification of PRKD1, JUN, and NCK1 as resistance-associated network nodes provides a framework for connecting early adaptive signaling with immune-relevant and extracellular-matrix changes.
-
Fluo-4 AM Workflows for Calcium Imaging
2026-08-22
Fluo-4 AM enables rapid, high-contrast monitoring of intracellular calcium in signaling, pharmacology, and bioelectronic assays. This practical guide connects reliable dye loading and troubleshooting with retinal-prosthesis research, while distinguishing calcium readouts from direct device-voltage measurements.
-
Coumestrol in RA Ferroptosis Research
2026-08-21
Coumestrol connects estrogen receptor biology with ferroptosis-based investigation in rheumatoid arthritis fibroblast-like synoviocytes. This workflow shows how to separate receptor effects from PMAIP1-dependent mitochondrial and inflammatory phenotypes while improving dose, vehicle, and assay controls.
-
GLT-1, CB1–CREB Signaling, and TBI Cognition
2026-08-21
A 2025 Biomolecules study identifies a mechanistic link between post-traumatic 2-AG/CB1 activity, reduced astrocytic GLT-1, glutamate excitotoxicity, neuronal apoptosis, and cognitive dysfunction. Using controlled cortical impact, pharmacological interventions, behavioral testing, and molecular assays, the authors show that CB1 blockade with AM281 preserves GLT-1 expression and improves injury-associated outcomes.
-
PPACK Dihydrochloride for Thrombin Assays
2026-08-20
PPACK Dihydrochloride provides high-affinity, irreversible thrombin suppression for platelet, coagulation, and thrombin signaling experiments. Its upstream mechanism complements receptor-selective tools such as NF449, helping researchers separate thrombin-driven effects from P2X1-dependent platelet activation.
-
nPEC for Dual-Loaded Liposome Encapsulation Efficiency
2026-08-20
The reference study compares six separation strategies for measuring encapsulation efficiency in dual-loaded liposomes containing hydrophilic and lipophilic drugs. Its main contribution is a validated nanoparticle exclusion chromatography approach that simultaneously quantifies both payloads without pretreatment, offering a practical analytical route for complex liposomal formulations.
-
4μ8C Workflows for ER Stress Signaling
2026-08-19
Use 4μ8C as a branch-selective tool to separate IRE1α RNase signaling from PERK-driven stress phenotypes, including pyroptosis and hypoxia responses. This workflow combines dose optimization, pathway-resolved controls, and practical handling guidance for cancer research and emerging nucleus pulposus cell models.
-
Fucoidan as a Mechanistic Bridge in Cancer Research
2026-08-19
Fucoidan research benefits from connecting apoptotic signaling with rigorous membrane-trafficking assay design. This article uses the CLCC1 herpesvirus study to show how C4038 can be evaluated without overstating antiviral or anticancer mechanisms.
-
Rotavirus Infection and Nrf2 Redox Defense
2026-08-18
The 2020 reference study shows that rotavirus infection produces a biphasic Nrf2 response: an early oxidative-stress-associated increase followed by marked Nrf2 depletion and loss of antioxidant transcription. Its combination of time-course analysis, pathway perturbation, and ubiquitination studies suggests that progressive infection engages proteasome-linked Nrf2 removal beyond canonical Keap1 regulation.